ADVANZ PHARMA logo

ADVANZ PHARMA

Partner of choice in specialty, hospital, and rare disease medicines

725 employees · est. 1963 · London, United Kingdom

VS
Incyte logo

Incyte

Pharmaceutical Research | Oncology Product Development | Incyte.com

3425 employees · est. 1991 · Wilmington, United States

ADVANZ PHARMA is the older company (1963 vs 1991); Incyte is the larger of the two.

Side-by-Side Comparison

ADVANZ PHARMA Incyte
Founded
1963 older 1991
Headquarters
London, United Kingdom Wilmington, United States
Employees
725 3425 larger
Industry
Health Care, Pharmaceutical Not tracked yet
Funding Stage
Post Ipo Equity IPO
Total Funding
$72.66M $44.30M
Funding Rounds
3 2
Services
Commercialization of specialty and rare disease medicines, Pharmaceutical development partnerships, Global distribution of medicines, Biosimilar portfolio development Development of innovative medicines, Research and development in Hematology and Oncology, Treatment for Inflammation and Autoimmunity, Clinical program management, Partnership development
Target Customers
Biopharma companies, Healthcare professionals, Hospitals, Healthcare systems Patients, Healthcare professionals, Medical institutions
Taxonomy
Specialty Medicines, Hospital Medicines, Rare Disease Medicines, Biopharma Partnerships, Global Pharmaceutical Company, Commercialisation Partner, Therapeutic Areas, Innovative Medicines, Specialty Generics, Biosimilars, Orphan Drugs, Oncology, Gastroenterology, Endocrinology, CNS Treatments Pharmaceutical Research, Oncology Product Development, Biopharmaceutical Company, Innovative Medicines, Clinical Candidates, Medicinal Chemistry, Inflammation & Autoimmunity, Dermatology, First-in-Class Medicines, Oncology, Targeted Therapy, Immuno-oncology, Immunology, Healthcare Advances, Pipeline Development
Website
advanzpharma.com incyte.com
ADVANZ PHARMA logo

About ADVANZ PHARMA

ADVANZ PHARMA positions itself as a leading global pharmaceutical firm focused on specialty, hospital, and rare disease medicines, serving a critical role in patient care by providing essential treatments worldwide. Established in 1963 and headquartered in the United Kingdom, the company offers a di...

Incyte logo

About Incyte

Incyte, founded in 1991, is a global leader in the biopharmaceutical landscape, known for its commitment to resolving unmet medical needs through innovative drug discovery and development in the fields of oncology and inflammation & autoimmunity. With its headquarters in Wilmington, Delaware, the co...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at ADVANZ PHARMA and Incyte — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at ADVANZ PHARMA and Incyte — by email.

Frequently Asked Questions

ADVANZ PHARMA — Partner of choice in specialty, hospital, and rare disease medicines. Incyte — Pharmaceutical Research | Oncology Product Development | Incyte.com. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ADVANZ PHARMA has raised $72.66M while Incyte has raised $44.30M.
ADVANZ PHARMA and Incyte operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ADVANZ PHARMA with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy